Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Children's National Hospital, Washington D.C., District of Columbia Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois Memorial Sloan Kettering Cancer Center, New York, New York